Oral hypoglycemic agents

2 papers1 finding

1 lab in 1 country

Humans1

Outcomes

1

Asymmetric dimethylarginine

downin humans1

1 study

Oral hypoglycemic agents decrease asymmetric dimethylarginine in humans.
“additional OHAs treatment significantly improved glycemic and metabolic parameters, and decreased ADMA concentrations.”
Human trialin 36 patients with type 2 diabetes mellitusn = 36
Clinical and biochemical factors associated with amygdalar metabolic activity
npj agingJan 25, 2025

More on Asymmetric dimethylarginine

Latest

1 in 12 months

World Journal of NephrologyAug 21

From kidney to liver: Are sodium-glucose cotransporter-2 inhibitors emerging as metabolic disease modifiers?

Meta-analysis of observational studiesSGLT2 inhibitors

npj AgingJan 26

Clinical and biochemical factors associated with amygdalar metabolic activity

Cohort study of 346 peopleBiomarkers